- $50.27m
- $67.37m
- $22.36m
Dario Health rises on strategic review after multiple inquiries
Brief: DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
Brief: Dariohealth Issues Shareholder Update Multi-Condition Leadership In Momentum Driven Digital Health Market
Brief: Dariohealth Corp Confident In Ability To Reach Approximately 40 New Client Signings By Year-End 2025-A 35% Increase Over 2024
Brief: Dariohealth Announces 20-To-1 Reverse Stock Split
DarioHealth Corp reports results for the quarter ended June 30 - Earnings Summary
Digital therapeutics platform DarioHealth Q2 revenue falls steeper-than-expected 14%
DarioHealth Corp expected to post a loss of 23 cents a share - Earnings Preview
Brief: Dario and Greenkey Health Partner to Improve Chronic Condition and Sleep Health Management Nationwide
DarioHealth Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: Dariohealth Reports First Quarter 2025 Financial
DarioHealth Corp expected to post a loss of 12 cents a share - Earnings Preview
Brief: DarioHealth Announces CFO Transition
Brief: Dariohealth Collaborates With Leading National Benefit Plan Administrator To Offer Cardiometabolic Solution
DarioHealth Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: DarioHealth Expects To Realize Additional 20% Reduction In Operating Expenses Between Q4 2025 & Q4 2025
Brief: Dariohealth Strategic Collaboration With Rula Health, To Expand Access To Mental Health Support For Employers, Workforce Nationwide
DarioHealth Corp expected to post a loss of 33 cents a share - Earnings Preview
Brief: DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets